Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology
TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …
original version published in 2011. They address the scope and targets of pharmacological …
Tardive syndromes
D Savitt, J Jankovic - Journal of the Neurological Sciences, 2018 - Elsevier
Tardive syndromes are a group of hyperkinetic and hypokinetic movement disorders that
occur after some delay following exposure to dopamine receptor blocking agents such as …
occur after some delay following exposure to dopamine receptor blocking agents such as …
Serotonin syndrome—a focused review
N Mikkelsen, P Damkier… - Basic & Clinical …, 2023 - Wiley Online Library
Background Serotonin syndrome is a potentially life‐threatening syndrome with
manifestations spanning from mild adverse effects to life‐threatening toxicity. The syndrome …
manifestations spanning from mild adverse effects to life‐threatening toxicity. The syndrome …
[HTML][HTML] A neurodevelopment approach for a transitional model of early onset schizophrenia
In the last decades, the conceptualization of schizophrenia has dramatically changed,
moving from a neurodegenerative process occurring in early adult life to a …
moving from a neurodegenerative process occurring in early adult life to a …
Risk factors, incidence, and outcomes of neuroleptic malignant syndrome on long-acting injectable vs oral antipsychotics in a nationwide schizophrenia cohort
Introduction Long-acting injectable antipsychotics (LAIs) are associated with multiple
positive outcomes in psychosis, but it is unclear whether LAIs are associated with worse …
positive outcomes in psychosis, but it is unclear whether LAIs are associated with worse …
[HTML][HTML] Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
NE Omori, MK Malys, G Woo, L Mansor - Frontiers in Psychiatry, 2023 - frontiersin.org
In recent times, advances in the field of metabolomics have shed greater light on the role of
metabolic disturbances in neuropsychiatric conditions. The following review explores the …
metabolic disturbances in neuropsychiatric conditions. The following review explores the …
Movement disorders emergencies
S Rajan, B Kaas, E Moukheiber - Seminars in neurology, 2019 - thieme-connect.com
Many acute and potentially life-threatening medical conditions have hyperkinetic or
hypokinetic movement disorders as their hallmark. Here we review the clinical …
hypokinetic movement disorders as their hallmark. Here we review the clinical …
Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review
HY Wang, T Li, XL Li, XX Zhang, ZR Yan… - … Disease and Treatment, 2019 - Taylor & Francis
Background Anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis is a severe
autoimmune disease characterized by complicated psychiatric and neurological symptoms …
autoimmune disease characterized by complicated psychiatric and neurological symptoms …
[HTML][HTML] Dopamine agonists
J Choi, KA Horner - 2019 - europepmc.org
Objectives: Identify the mechanism of action of dopamine agonists. Describe the potential
adverse effects of dopamine agonists. Review the toxicity of dopamine agonists. Summarize …
adverse effects of dopamine agonists. Review the toxicity of dopamine agonists. Summarize …